2-chloro-N,N-dimethylacetamide → HCID 58529364, compound
Reaction equation
[NH2:1][C:2]1[N:3]([CH2:27][C:28]2[CH:33]=[CH:32][CH:31]=[CH:30][C:29]=2[F:34])[N:4]=[C:5]2[C:10]=1[CH:9]=[CH:8][C:7]([C:11]1[CH:12]=[C:13]([CH:21]3[CH2:26][CH2:25][NH:24][CH2:23][CH2:22]3)[N:14]3[C:19]=1[C:18]([NH2:20])=[N:17][CH:16]=[N:15]3)=[CH:6]2.Cl[CH2:36][C:37]([N:39]([CH3:41])[CH3:40])=[O:38].CCN(C(C)C)C(C)C>C1COCC1.CO>[NH2:20][C:18]1[C:19]2=[C:11]([C:7]3[CH:8]=[CH:9][C:10]4[C:5]([CH:6]=3)=[N:4][N:3]([CH2:27][C:28]3[CH:33]=[CH:32][CH:31]=[CH:30][C:29]=3[F:34])[C:2]=4[NH2:1])[CH:12]=[C:13]([CH:21]3[CH2:26][CH2:25][N:24]([CH2:36][C:37]([N:39]([CH3:41])[CH3:40])=[O:38])[CH2:23][CH2:22]3)[N:14]2[N:15]=[CH:16][N:17]=1Participants
6
Reactant 3
Product 1
Reagents, catalysts & solvents 2
Procedure
To a suspension of 5-[3-amino-2-(2-fluorobenzyl)-2H-indazol-6-yl]-7-piperidin-4-ylpyrrolo[2,1-f][1,2,4]triazin-4-amine (0.1 g, 0.22 mmol) in THF (2 mL) was added 2-chloro-N,N-dimethylacetamide (0.024 g, 0.2 mmol) and DIEA (0.11 g, 0.88 mmol). The mixture was stirred at room temperature for 18 h, diluted with methanol, and concentrated. The crude product was purified by HPLC (10 to 90% CH3CN). 1H NMR (400 MHz, CD2Cl2) δ 7.87 (s, 1 H) 7.58 (d, 1 H) 7.11-7.35 (m, 5 H) 7.01 (d, 1 H) 6.55 (s, 1 H) 5.50-5.55 (m, 4 H) 4.25 (s, 2 H) 2.90-3.30 (m, 11 H) 2.30 (dt, 2 H) 2.10 (d, 2 H) 1.83 (dt, 2 H). LC-MS [M+H]+=542.3, RT=0.31 min.
Workup
- concentrationconcentrated
- customThe crude product was purified by HPLC (10 to 90% CH3CN)
Sources & evidence
- ORD record
- ord-2086be67d4a4489b9ea23d73a5683b95
- Source dataset
- uspto-grants-2013_04
- Patent number
- US08431695B2
Reaction notes
Loading…